Preparing your experience...
Preparing your experience...
Connect AlgoVigilance Station to Claude and get instant access to 2,000+ pharmacovigilance tools — FDA adverse event data, drug labeling, clinical trials, published literature, and more.
Free. No API key. No account needed. Takes about 60 seconds.
AlgoVigilance Station is a tool server that gives Claude (the AI you chat with on claude.ai) the ability to look up real drug safety data. Without it, Claude answers from memory. With it, Claude can search live FDA databases, compute safety statistics, and cite real evidence — just like a pharmacovigilance analyst would.
Think of it like installing an app on your phone. You're giving Claude a new capability. The setup takes 3 clicks.
Go to claude.ai and look for the gear icon ( Settings) in the bottom-left corner of the sidebar.
Click: Settings (gear icon, bottom-left)
Then click: “Integrations” in the left menu
Then click: “Add More” or “Add Integration”
When Claude asks for a server URL, paste this. That's the address of our tool server.
https://mcp.nexvigilant.com/mcpClick the copy button, then paste into Claude's URL field. No name or other settings needed.
Go back to a Claude conversation and ask any drug safety question. Claude will automatically use AlgoVigilance Station to search live databases and give you evidence-based answers.
Try typing:
“Investigate the safety signal for semaglutide and pancreatitis”
Claude will search FDA data, compute disproportionality scores, check drug labels, and search published literature.
That's it. You now have 2,000+ PV tools in Claude.
Once connected, try any of these. Claude will use AlgoVigilance Station tools automatically.
“Investigate semaglutide and pancreatitis”
Full signal detection pipeline — FAERS, disproportionality, labeling, literature
“What are the adverse reactions for metformin?”
Drug labeling lookup via DailyMed
“Compare the safety profiles of warfarin and apixaban”
Head-to-head FAERS analysis with disproportionality
“Search for clinical trials studying statin-related myopathy”
ClinicalTrials.gov safety endpoint search
“Run a benefit-risk assessment for ibuprofen”
Multi-source assessment: trials, FAERS, labeling, literature
For structured investigations, tell Claude to “chart a course for [topic]”. It will follow a multi-step research protocol:
Drug Safety Profile
6 steps: Name → FAERS → ADRs → Literature → EU → WHO
Signal Investigation
6 steps: FAERS → Disproportionality → EU → Case Reports → Trials → PRAC
Causality Assessment
4 steps: FAERS → Disproportionality → WHO-UMC → Case Reports
Benefit-Risk Assessment
4 steps: Trials → FAERS → Labels → EU RMP
Regulatory Intelligence
3 steps: ICH → EU EPAR → FDA Approvals
Competitive Landscape
3 steps: Targets → Head-to-Head → Pipeline
Watch a complete signal investigation run in your browser — no setup required. Then come back and connect your own Claude.
Watch the Semaglutide Demohttps://mcp.nexvigilant.com/mcp{"mcpServers":{"nexvigilant":{"url":"https://mcp.nexvigilant.com/mcp"}}}